About
Nimble Science is a Calgary-based biotechnology and medical device company that specializes in gut microbiome analysis using its proprietary ingestible technology. The company's flagship product is the Small Intestine MicroBiome Aspiration (SIMBA) Capsule, a swallowable device designed to sample the microbiome of the small intestine, an area that has been challenging to access and study. The company operates in the B2B sector, offering the SIMBA Capsule along with the GI Intelligence Platform, which provides multi-omic insights from collected gut samples. This platform supports applications in therapeutic development, diagnostics, precision medicine, and clinical research. Nimble Science collaborates with academic researchers, pharmaceutical companies, consumer health brands, and clinical research organizations to enhance drug development and personalized diagnostics. Founded by Dr. Joseph Wang and Dr. Sabina Bruehlmann, Nimble Science has evolved from academic research at the University of Calgary and has successfully raised over $2 million in seed funding to further its innovative platform and expand its market presence.
Technologies
Keywords
Company Information
- Employees26
- Founded2018
- Annual Revenue$3000000
- Total Funding$2000000
Location
3655 36 St NW, Calgary, Alberta, Canada, T2L 1Y8
